Category: ADMS Soars On FDA Nod

ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB’s Humira Biosim

  1. ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB’s Humira Biosim  Nasdaq
  2. Adamas Pharma (ADMS) Scores FDA Approval for Parkinson’s Drug  Economic Calendar
  3. Adamas Pharmaceuticals Inc Won FDA Approval; Shares Hit 52-Week High  Smarter Analyst
  4. Full coverage

from Business – Google News http://www.nasdaq.com/article/adms-soars-on-fda-nod-ears-gets-an-earful-thumbs-up-for-biibs-humira-biosim-20170825-00064

Advertisements